Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Crinetics Pharmaceuticals revenue
Crinetics Pharmaceuticals's revenue is $1.0 million.
What is Crinetics Pharmaceuticals's revenue?
- Crinetics Pharmaceuticals's revenue growth from 2017 to 2024 is -49.19%.
- Crinetics Pharmaceuticals has 50 employees, and the revenue per employee ratio is $20,780.
- Crinetics Pharmaceuticals's peak quarterly revenue was $3.1M in 2022(q1).
- Crinetics Pharmaceuticals peak revenue was $4.7M in 2022.
- Crinetics Pharmaceuticals annual revenue for 2023 was 4.0M, -15.28% growth from 2022.
- Crinetics Pharmaceuticals annual revenue for 2024 was 1.0M, -74.11% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Crinetics Pharmaceuticals historical revenue
Crinetics Pharmaceuticals's peak revenue was $4.7M in 2022. The peak quarterly revenue was $3.1M in 2022(q1).
Crinetics Pharmaceuticals's revenue increased from $2.0m in 2017 to $1.0M currently. That's a -49.19% change in annual revenue.
Crinetics Pharmaceuticals annual revenue
Crinetics Pharmaceuticals annual revenue over time
| Fiscal year / year | Crinetics Pharmaceuticals revenue |
|---|---|
| 2017 | $2.0M |
| 2018 | $2.4M |
| 2019 | $1.2M |
| 2020 | $71,000 |
| 2021 | $1.1M |
| 2022 | $4.7M |
| 2023 | $4.0M |
| 2024 | $1.0M |
Rate Crinetics Pharmaceuticals' financial transparency
Crinetics Pharmaceuticals annual growth
Crinetics Pharmaceuticals saw the greatest revenue growth in 2021, when revenue increased by 1,418.31%.
Crinetics Pharmaceuticals had the lowest revenue growth in 2020, when revenue changed by -94.05%.
Crinetics Pharmaceuticals annual growth rate over time
| Year | Crinetics Pharmaceuticals growth |
|---|---|
| 2018 | 19%↑ |
| 2019 | -51%↓ |
| 2020 | -94%↓ |
| 2021 | 1418%↑ |
| 2022 | 339%↑ |
| 2023 | -15%↓ |
| 2024 | -74%↓ |
Crinetics Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Crinetics Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | - | $1.1M |
| 2022 | $3.1M | $439,000 | $458,000 | $709,000 |
| 2023 | $2.7M | $988,000 | $346,000 | - |
| 2024 | $640,000 | $399,000 | - | - |
Crinetics Pharmaceuticals jobs nearby
Do you work at Crinetics Pharmaceuticals?
Did Crinetics Pharmaceuticals meet its revenue projections?
Crinetics Pharmaceuticals financing
Crinetics Pharmaceuticals received early financing of $2.2M on 2013-09-03.
| Series | Round size | Date |
|---|---|---|
| Grant | $2.2M | 09/2013 |
| Grant | $1.5M | 01/2015 |
| Grant | $2.7M | 04/2015 |
| Series A | $40M | 11/2015 |
| Grant | $2.8M | 07/2017 |
| Series B | $63.5M | 03/2018 |
| Grant | $3.2M | 06/2018 |
| Post Ipo Equity | $115.1M | 04/2020 |
| Post Ipo Equity | $75M | 04/2021 |
| Post Ipo Equity | $15M | 07/2021 |
Crinetics Pharmaceuticals investors
| Investors | Security type |
|---|---|
| National Institutes of Health (NIH) | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Versant Ventures | Series A |
| 5 Am Ventures | Series A |
| Vivo Capital | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Grant |
| Versant Ventures | Series B |
| Vivo Capital | Series B |
| 5 Am Ventures | Series B |
| Perceptive Advisors | Series B |
| OrbiMed Advisors | Series B |
| RA Capital Management | Series B |
| National Institutes of Health (NIH) | Grant |
| Bain Capital Life Sciences | Post Ipo Equity |
| Deep Track Capital LP | Post Ipo Equity |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Post Ipo Equity |
| Frazier Healthcare Partners | Post Ipo Equity |
Crinetics Pharmaceuticals revenue FAQs
Search for jobs
Crinetics Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Crinetics Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Crinetics Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Crinetics Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Crinetics Pharmaceuticals. The data presented on this page does not represent the view of Crinetics Pharmaceuticals and its employees or that of Zippia.
Crinetics Pharmaceuticals may also be known as or be related to CRINETICS PHARMACEUTICALS, INC., Crinetics Pharmaceuticals and Crinetics Pharmaceuticals, Inc.